New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
08:39 EDTASTM, SNYAastrom appoints Chief Scientific Officer, Chief Medical Officer
Aastrom Biosciences announced the appointments of Ross Tubo, PhD, as Chief Scientific Officer and David Recker, MD, FACR, FACP, as Chief Medical Officer of Aastrom. Dr. Tubo was formerly vice president of stem cell and chemokine biology at Genzyme, a Sanofi company (SNY). Dr. Recker most recently served as a senior vice president of clinical sciences at Takeda Global Research and Development.
News For ASTM;SNY From The Last 14 Days
Check below for free stories on ASTM;SNY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
07:11 EDTSNYInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
July 16, 2014
09:03 EDTSNYSanofi held talks on mature drugs with Abbott, Mylan, PE firms, Reuters says
Sanofi (SNY) has shopped an $8.5B portfolio of mature drugs to Abbott (ABT), Mylan (MYL) and private equity firms, according to Reuters, citing an internal company document circulated by the CGT union. Sanofi is considering whether to sell, carve out or create a joint venture for the portfolio of about 200 drugs, but a Sanofi spokesman said no decision has yet been made, the report noted. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use